Hill-Rom Holdings, Inc. (NYSE:HRC) reached a new 52-week high on Tuesday . The stock traded as high as $94.72 and last traded at $94.23, with a volume of 536165 shares trading hands. The stock had previously closed at $91.38.
Several research firms have recently weighed in on HRC. KeyCorp reissued an “overweight” rating and issued a $115.00 price objective (up from $97.00) on shares of Hill-Rom in a report on Tuesday. ValuEngine downgraded Hill-Rom from a “buy” rating to a “hold” rating in a report on Saturday, June 16th. Needham & Company LLC reissued a “buy” rating and issued a $106.00 price objective (up from $105.00) on shares of Hill-Rom in a report on Monday, April 30th. Zacks Investment Research raised Hill-Rom from a “hold” rating to a “buy” rating and set a $96.00 price objective for the company in a report on Thursday, April 5th. Finally, Goldman Sachs Group began coverage on Hill-Rom in a report on Wednesday, April 4th. They issued a “neutral” rating and a $85.00 price objective for the company. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $97.00.
Get Hill-Rom alerts:The firm has a market cap of $6.05 billion, a price-to-earnings ratio of 24.41, a P/E/G ratio of 1.42 and a beta of 0.96. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.85 and a quick ratio of 1.36.
Hill-Rom (NYSE:HRC) last posted its quarterly earnings data on Friday, April 27th. The medical technology company reported $1.05 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.02 by $0.03. The business had revenue of $710.50 million during the quarter, compared to the consensus estimate of $707.54 million. Hill-Rom had a return on equity of 20.18% and a net margin of 6.85%. The company’s revenue was up 4.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.88 earnings per share. research analysts anticipate that Hill-Rom Holdings, Inc. will post 4.63 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, June 29th. Investors of record on Friday, June 22nd were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend was Thursday, June 21st. Hill-Rom’s dividend payout ratio is presently 20.73%.
In related news, SVP Paul Sherwood Johnson sold 5,168 shares of the stock in a transaction on Friday, May 25th. The stock was sold at an average price of $90.88, for a total transaction of $469,667.84. Following the completion of the sale, the senior vice president now directly owns 4,063 shares of the company’s stock, valued at $369,245.44. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Alton Shader sold 16,812 shares of the stock in a transaction on Monday, June 11th. The stock was sold at an average price of $93.70, for a total value of $1,575,284.40. Following the sale, the senior vice president now directly owns 54,898 shares of the company’s stock, valued at $5,143,942.60. The disclosure for this sale can be found here. 1.90% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently modified their holdings of HRC. Vigilant Capital Management LLC acquired a new stake in shares of Hill-Rom during the second quarter worth $109,000. Three Peaks Capital Management LLC acquired a new stake in shares of Hill-Rom during the first quarter worth $111,000. Point72 Asia Hong Kong Ltd lifted its holdings in shares of Hill-Rom by 1,978.1% during the first quarter. Point72 Asia Hong Kong Ltd now owns 1,330 shares of the medical technology company’s stock worth $116,000 after purchasing an additional 1,266 shares during the period. We Are One Seven LLC acquired a new stake in shares of Hill-Rom during the fourth quarter worth $188,000. Finally, Campbell & CO Investment Adviser LLC acquired a new stake in shares of Hill-Rom during the first quarter worth $203,000. 81.15% of the stock is owned by hedge funds and other institutional investors.
Hill-Rom Company Profile
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Featured Story: Stock Ratings and Recommendations: Understanding Analyst Upgrades and Downgrades
No comments:
Post a Comment